Importer of Controlled Substances Application: NSI Lab Solutions, Inc., 37257-37260 [2024-09811]
Download as PDF
37257
Federal Register / Vol. 89, No. 88 / Monday, May 6, 2024 / Notices
Controlled substance
Drug code
Phenazocine ........................................................................................................................................................................
Thiafentanil ..........................................................................................................................................................................
Piminodine ...........................................................................................................................................................................
Racemethorphan .................................................................................................................................................................
Racemorphan ......................................................................................................................................................................
Alfentanil ..............................................................................................................................................................................
Remifentanil .........................................................................................................................................................................
Sufentanil .............................................................................................................................................................................
Carfentanil ...........................................................................................................................................................................
Tapentadol ...........................................................................................................................................................................
Bezitramide ..........................................................................................................................................................................
Fentanyl ...............................................................................................................................................................................
Moramide-intermediate ........................................................................................................................................................
The company plans to import
analytical reference standards for
distribution to its customers for research
and analytics purposes. Placement of
these drug codes onto the company’s
registration does not translate into
automatic approval of subsequent
permit applications to import controlled
substances.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized in 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
Marsha Ikner,
Acting Deputy Assistant Administrator.
[FR Doc. 2024–09803 Filed 5–3–24; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–1361]
Importer of Controlled Substances
Application: NSI Lab Solutions, Inc.
Drug Enforcement
Administration, Justice.
AGENCY:
ACTION:
Notice of application.
NSI Lab Solutions, Inc. has
applied to be registered as an importer
of basic class(es) of controlled
substance(s). Refer to SUPPLEMENTARY
INFORMATION listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before June 5, 2024. Such persons
may also file a written request for a
hearing on the application on or before
June 5, 2024.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
SUMMARY:
In
accordance with 21 CFR 1301.34(a), this
is notice that on March 22, 2024, NSI
Lab Solutions, Inc., 7212 ACC
Boulevard, Raleigh, North Carolina
27617, applied to be registered as an
importer of the following basic class(es)
of controlled substance(s):
SUPPLEMENTARY INFORMATION:
ddrumheller on DSK120RN23PROD with NOTICES1
Drug code
3-Fluoro-N-methylcathinone (3–FMC) .................................................................................................................................
Cathinone ............................................................................................................................................................................
Methcathinone .....................................................................................................................................................................
4-Fluoro-N-methylcathinone (4–FMC) .................................................................................................................................
Pentedrone (a-methylaminovalerophenone) .......................................................................................................................
Mephedrone (4-Methyl-N-methylcathinone) ........................................................................................................................
4-Methyl-N-ethylcathinone (4–MEC) ...................................................................................................................................
Naphyrone ...........................................................................................................................................................................
3-methylmethcathinone (2-(methylamino)-1-(3- methylphenyl)propan-1-one) ....................................................................
N-Ethylamphetamine ...........................................................................................................................................................
Methiopropamine (N-methyl-1-(thiophen-2-yl)propan-2- amine) .........................................................................................
N,N-Dimethylamphetamine ..................................................................................................................................................
Fenethylline .........................................................................................................................................................................
Aminorex ..............................................................................................................................................................................
4-Methylaminorex (cis isomer) ............................................................................................................................................
4,4′-Dimethylaminorex (4,4′-DMAR; 4,5-dihydro-4- methyl-5-(4-methylphenyl)-2-oxazolamine; 4-methyl-5- (4methylphenyl)-4,5-dihydro-1,3-oxazol-2-amine).
18:02 May 03, 2024
Jkt 262001
PO 00000
Frm 00098
Fmt 4703
Sfmt 4703
II
II
II
II
II
II
II
II
II
II
II
II
II
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment. All
requests for a hearing must be sent to:
(1) Drug Enforcement Administration,
Attn: Hearing Clerk/OALJ, 8701
Morrissette Drive, Springfield, Virginia
22152; and (2) Drug Enforcement
Administration, Attn: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing should
also be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152.
Controlled substance
VerDate Sep<11>2014
9715
9729
9730
9732
9733
9737
9739
9740
9743
9780
9800
9801
9802
Schedule
E:\FR\FM\06MYN1.SGM
06MYN1
1233
1235
1237
1238
1246
1248
1249
1258
1259
1475
1478
1480
1503
1585
1590
1595
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
37258
Federal Register / Vol. 89, No. 88 / Monday, May 6, 2024 / Notices
ddrumheller on DSK120RN23PROD with NOTICES1
Controlled substance
Drug code
Gamma Hydroxybutyric Acid ...............................................................................................................................................
Methaqualone ......................................................................................................................................................................
Etizolam (4-(2-chlorophenyl)-2-ethyl-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine ....................................
Flualprazolam (8-chloro-6-(2-fluorophenyl)-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine) ...............................
Clonazolam (6-(2-chlorophenyl)-1-methyl-8-nitro-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine ......................................
Flubromazolam (8-bromo-6-(2-fluorophenyl)-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine ..............................
Diclazepam (7-chloro-5-(2-chloro-5-(2-chlorophenyl)-1- methyl-1,3-dihydro-2H-benzo[e][1,4]diazepin-2-one ...................
JWH–250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) ......................................................................................................
SR–18 (Also known as RCS–8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) indole) ....................................................
ADB–FUBINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) .................
5-Fluoro-UR–144 and XLR11 ([1-(5-Fluoro-pentyl)1H-indol-3-yl] (2,2,3,3-tetramethylcyclopropyl)methanone) ................
AB–FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) .........................
(1-(4-Fluorobenzyl)-1H-indol-3-yl)(2,2,3,3- tetramethylcyclopropyl)methanone ..................................................................
JWH–019 (1-Hexyl-3-(1-naphthoyl) indole) .........................................................................................................................
MDMB–FUBINACA (Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) ..........................
FUB–AMB, MMB–FUBINACA, AMB–FUBINACA (2-(1-(4-fluorobenzyl)-1Hindazole-3-carboxamido)-3-methylbutanoate)
AB–PINACA (N-(1-amino-3-methyl- ....................................................................................................................................
1-oxobutan-2-yl)-1-pentyl-1H-indazole-)3-carboxamide ......................................................................................................
THJ–2201 ([1-(5-fluoropentyl)-1H-indazol-3- .......................................................................................................................
yl](naphthalen-1-yl)methanone) ...........................................................................................................................................
5F–AB–PINACA (N-(1-amino-3methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide) ..........................
ADB–BUTINACA (N-(1-amino-3,3-dimethyl-1-oxobutan2-yl)-1-butyl-1H-indazole-3-carb ..................................................
AB–CHMINACA (N-(1-amino-3-methyl-1- ...........................................................................................................................
oxobutan-2-yl)-1-(cyclohexylmethyl)- ...................................................................................................................................
1H-indazole-3-carboxamide) ...............................................................................................................................................
MAB–CHMINACA (N-(1-amino-3,3dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide) ............
5F–AMB (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate) ..................................................
ADB–PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) .....................................
Methyl 2-(1-(5-fluoropentyl)-1H-indole-3-carboxamido)- 3,3-dimethylbutanoate ................................................................
MDMB–CHMICA, MMB–CHMINACA (Methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3dimethylbutanoate).
4F–MDMB–BINACA (4F–MDMB–BUTINACA or methyl 2- (1-(4-fluorobutyl)-1H-indazole-3-carboxamido)-3,3dimethylbutanoate).
MMB–CHMICA, AMB–CHMICA (methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3-methylbutanoate) ............
APINACA and AKB48 (N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide) ................................................................
JWH–081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) indole) ......................................................................................................
MDMB–4en-PINACA (methyl 3,3-dimethyl-2-(1-(pent-4- en-1-yl)-1H-indazole-3-carboxamido)butanoate) .......................
SR–19 (Also known as RCS–4) (1-Pentyl-3-[(4-methoxy)-benzoyl] indole) .......................................................................
JWH–018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) ..................................................................................
JWH–122 (1-Pentyl-3-(4-methyl-1-naphthoyl) indole) .........................................................................................................
UR–144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone) ....................................................................
JWH–073 (1-Butyl-3-(1-naphthoyl)indole) ...........................................................................................................................
JWH–200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole) ..............................................................................................
AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole) ...........................................................................................................
JWH–203 (1-Pentyl-3-(2-chlorophenylacetyl) indole) ..........................................................................................................
NM2201, CBL2201 (Naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate) .............................................................
PB–22 (Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate) .....................................................................................................
5F–PB–22 (Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate) ................................................................................
Alpha-ethyltryptamine ..........................................................................................................................................................
Ibogaine ...............................................................................................................................................................................
Lysergic acid diethylamide ..................................................................................................................................................
Marihuana extract ................................................................................................................................................................
Marihuana ............................................................................................................................................................................
Tetrahydrocannabinols ........................................................................................................................................................
Mescaline .............................................................................................................................................................................
JWH–398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole) ..........................................................................................................
3,4-Methylenedioxyamphetamine ........................................................................................................................................
3,4-Methylenedioxymethamphetamine ................................................................................................................................
Alpha-methyltryptamine .......................................................................................................................................................
Bufotenine ............................................................................................................................................................................
Diethyltryptamine .................................................................................................................................................................
Dimethyltryptamine ..............................................................................................................................................................
Psilocybin .............................................................................................................................................................................
Psilocyn ...............................................................................................................................................................................
4-chloro-alpha-pyrrolidinovalerophenone (4-chloro-a-PVP) ................................................................................................
N-Benzylpiperazine ..............................................................................................................................................................
2C–I (2-(4-iodo-2,5-dimethoxyphenyl) ethanamine) ............................................................................................................
2C–N (2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine) ........................................................................................................
2C–P (2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine) .................................................................................................
MDPV (3,4-Methylenedioxypyrovalerone) ...........................................................................................................................
2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25C–NBOMe) ........................................................
Methylone (3,4-Methylenedioxy-N-methylcathinone) ..........................................................................................................
Butylone ...............................................................................................................................................................................
Pentylone .............................................................................................................................................................................
VerDate Sep<11>2014
18:02 May 03, 2024
Jkt 262001
PO 00000
Frm 00099
Fmt 4703
Sfmt 4703
E:\FR\FM\06MYN1.SGM
06MYN1
Schedule
2010
2565
2780
2785
2786
2788
2789
6250
7008
7010
7011
7012
7014
7019
7020
7021
7023
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
7024
I
7025
7027
7031
I
I
I
7032
7033
7035
7041
7042
I
I
I
I
I
7043
I
7044
7048
7081
7090
7104
7118
7122
7144
7173
7200
7201
7203
7221
7222
7225
7249
7260
7315
7350
7360
7370
7381
7398
7400
7405
7432
7433
7434
7435
7437
7438
7443
7493
7518
7521
7524
7535
7537
7540
7541
7542
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
37259
Federal Register / Vol. 89, No. 88 / Monday, May 6, 2024 / Notices
ddrumheller on DSK120RN23PROD with NOTICES1
Controlled substance
Drug code
N-Ethylpentylone, ephylone (1-(1,3-benzodioxol-5-yl)-2-(ethylamino)-pentan-1-one) ........................................................
a-PVP (alpha-pyrrolidinopentiophenone) ............................................................................................................................
a-PBP (alpha-pyrrolidinobutiophenone) ..............................................................................................................................
Ethylone ...............................................................................................................................................................................
PV8, alpha-Pyrrolidinoheptaphenone ..................................................................................................................................
Eutylone ...............................................................................................................................................................................
a-PiHP (4-methyl-1-phenyl-2-(pyrrolidin-1-yl)pentan-1- one) ..............................................................................................
AM–694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole) .......................................................................................................
Acetyldihydrocodeine ...........................................................................................................................................................
Codeine-N-oxide ..................................................................................................................................................................
Desomorphine .....................................................................................................................................................................
Brorphine (1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)- 1,3-dihydro-2H-benzo[d]imidazol-2-one) ....................................
Heroin ..................................................................................................................................................................................
Morphine-N-oxide ................................................................................................................................................................
Myrophine ............................................................................................................................................................................
Nicomorphine .......................................................................................................................................................................
Normorphine ........................................................................................................................................................................
Pholcodine ...........................................................................................................................................................................
Thebacon .............................................................................................................................................................................
U–47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide) ..................................................................
AH–7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide)) ......................................................................
MT–45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine)) ......................................................................................................
Isotonitazene (N,N-diethyl-2-(2-(4 isopropoxybenzyl)-5- nitro-1H-benzimidazol-1-yl)ethan-1-amine) ................................
Dimethylthiambutene ...........................................................................................................................................................
Dipipanone ...........................................................................................................................................................................
Etonitazene ..........................................................................................................................................................................
Ketobemidone ......................................................................................................................................................................
Tilidine .................................................................................................................................................................................
Butonitazene (2-(2-(4-butoxybenzyl)-5-nitro-1Hbenzimidazol-1-yl)-N,N-diethylethan-1 ......................................................
Flunitazene (N,N-diethyl-2-(2-(4-fluorobenzyl)-5-nitro1H-benzimidazol-1-yl)ethan-1-amine) .............................................
Metonitazene (N,N-diethyl-2-(2-(4-methoxybenzyl)-5- nitro-1H-benzimidazol-1-yl)ethan-1-amine) ...................................
N-pyrrolidino etonitazene; etonitazepyne (2-(4-ethoxybenzyl)-5-nitro-1-(2- (pyrrolidin-1-yl)ethyl)- 1H-benzimidazole) .....
Metodesnitazene (N,N-diethyl-2-(2-(4-methoxybenzyl)- 1H-benzimidazol-1-yl)ethan-1-amine) .........................................
Metodesnitazene (N,N-diethyl-2-(2-(4-methoxybenzyl)- 1H-benzimidazol-1-yl)ethan-1-amine) .........................................
Etodesnitazene; etazene (2-(2-(4-ethoxybenzyl)-1Hbenzimidazol-1-yl)-N,N-diethyleth .....................................................
Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide) .....................................................................................
Para-Fluorofentanyl .............................................................................................................................................................
3-Methylfentanyl ..................................................................................................................................................................
Alpha-Methylfentanyl ...........................................................................................................................................................
Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) ...................................................................................
Butyryl Fentanyl ...................................................................................................................................................................
Para-fluorobutyryl fentanyl ...................................................................................................................................................
4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide) .............................................
2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide .............................................................................................
Para-chloroisobutyryl fentanyl .............................................................................................................................................
Isobutyryl fentanyl ................................................................................................................................................................
Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide) .................................................................
Thiofentanyl .........................................................................................................................................................................
Beta-hydroxythiofentanyl .....................................................................................................................................................
Ocfentanil .............................................................................................................................................................................
Valeryl fentanyl ....................................................................................................................................................................
Phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-Nphenylbenzamide; also known as benzoyl fentanyl) ..............................
beta′-Phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N,3- diphenylpropanamide; also known as b′-phenyl fentanyl; 3phenylpropanoyl fentanyl).
N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide) .............................................................................
Crotonyl fentanyl ((E)-N-(1-phenethylpiperidin-4-yl)-Nphenylbut-2-enam ...........................................................................
Cyclopropyl Fentanyl ...........................................................................................................................................................
Cyclopentyl fentanyl ............................................................................................................................................................
Fentanyl related-compounds as defined in 21 CFR 1308.11(h) .........................................................................................
2′-Fluoro ortho-fluorofentanyl (N-(1-(2- fluorophenethyl)piperidin-4-yl)-N-(2- fluorophenyl)propionamide; also known as
2’-fluoro 2- fluorofentanyl).
Amphetamine .......................................................................................................................................................................
Methamphetamine ...............................................................................................................................................................
ANPP (4-Anilino-N-phenethyl-4-piperidine) .........................................................................................................................
Norfentanyl (N-phenyl-N-(piperidin-4-yl)propionamide) .......................................................................................................
1-Piperidinocyclohexanecarbonitrile ....................................................................................................................................
Cocaine ................................................................................................................................................................................
Codeine ...............................................................................................................................................................................
Dihydrocodeine ....................................................................................................................................................................
Oxycodone ...........................................................................................................................................................................
Hydromorphone ...................................................................................................................................................................
Diphenoxylate ......................................................................................................................................................................
Ecgonine ..............................................................................................................................................................................
Ethylmorphine ......................................................................................................................................................................
VerDate Sep<11>2014
18:02 May 03, 2024
Jkt 262001
PO 00000
Frm 00100
Fmt 4703
Sfmt 4703
E:\FR\FM\06MYN1.SGM
06MYN1
Schedule
7543
7545
7546
7547
7548
7549
7551
7694
9051
9053
9055
9098
9200
9307
9308
9312
9313
9314
9315
9547
9551
9560
9614
9619
9622
9624
9628
9750
9751
9756
9757
9758
9759
9764
9765
9811
9812
9813
9814
9821
9822
9823
9824
9825
9826
9827
9834
9835
9836
9838
9840
9841
9842
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
9843
9844
9845
9847
9850
9855
I
I
I
I
I
I
1100
1105
8333
8366
8603
9041
9050
9120
9143
9150
9170
9180
9190
II
II
II
II
II
II
II
II
II
II
II
II
II
37260
Federal Register / Vol. 89, No. 88 / Monday, May 6, 2024 / Notices
Controlled substance
Drug code
Hydrocodone .......................................................................................................................................................................
Levorphanol .........................................................................................................................................................................
Isomethadone ......................................................................................................................................................................
Meperidine ...........................................................................................................................................................................
Meperidine-intermediate-A ..................................................................................................................................................
Meperidine intermediate-B ..................................................................................................................................................
Meperidine intermediate-C ..................................................................................................................................................
Methadone ...........................................................................................................................................................................
Methadone intermediate ......................................................................................................................................................
Dextropropoxyphene, bulk (non-dosage forms) ..................................................................................................................
Morphine ..............................................................................................................................................................................
Oripavine .............................................................................................................................................................................
Thebaine ..............................................................................................................................................................................
Opium, raw ..........................................................................................................................................................................
Opium extracts ....................................................................................................................................................................
Opium fluid extract ..............................................................................................................................................................
Opium tincture .....................................................................................................................................................................
Opium, powdered ................................................................................................................................................................
Opium, granulated ...............................................................................................................................................................
Oxymorphone ......................................................................................................................................................................
Noroxymorphone .................................................................................................................................................................
Alfentanil ..............................................................................................................................................................................
Remifentanil .........................................................................................................................................................................
Sufentanil .............................................................................................................................................................................
Carfentanil ...........................................................................................................................................................................
Tapentadol ...........................................................................................................................................................................
Bezitramide ..........................................................................................................................................................................
Fentanyl ...............................................................................................................................................................................
The company plans to import the
listed controlled substances for sale to
research facilities for drug testing and
analysis. In reference to drug codes 7360
(Marihuana) and 7370
(Tetrahydrocannabinols) the company
plans to import a synthetic cannabidiol
and a synthetic tetrahydrocannabinol.
No other activities for these drug codes
are authorized for this registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
The Drug Enforcement
Administration (DEA) published a
document in the Federal Register on
March 6, 2024, concerning an
application for an Importer of
Controlled Substances. The document
request removal of Dimethyltrytamine.
SUMMARY:
SUPPLEMENTARY INFORMATION:
In the Federal Register on March 6,
2024, in FR Doc No: 89 FR 16029, FR
No. 2024–04753, on pages 16029–16030
(2 pages), in the first column, remove
the controlled substance
Dimethltrytamine from the list to read
as follows:
Controlled substance
Drug
code
Schedule
[FR Doc. 2024–09811 Filed 5–3–24; 8:45 am]
Cocaine ........................
Methadone ....................
9041
9250
II
II
I
Marsha Ikner,
Acting Deputy Assistant Administrator.
Drug Enforcement Administration
[FR Doc. 2024–09785 Filed 5–3–24; 8:45 am]
BILLING CODE P
ddrumheller on DSK120RN23PROD with NOTICES1
I
DEPARTMENT OF JUSTICE
[Docket No. 1324]
Importer of Controlled Substances
Application: AndersonBrecon dba PCI
Pharma Services; Correction
Drug Enforcement
Administration, Justice.
ACTION: Notice of correction.
AGENCY:
VerDate Sep<11>2014
18:02 May 03, 2024
Jkt 262001
PO 00000
Frm 00101
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–1357]
Bulk Manufacturer of Controlled
Substances Application: Pharmaron
Manufacturing Services (US) LLC
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Correction
Marsha Ikner,
Acting Deputy Assistant Administrator.
BILLING CODE 4410–09–P
9193
9220
9226
9230
9232
9233
9234
9250
9254
9273
9300
9330
9333
9600
9610
9620
9630
9639
9640
9652
9668
9737
9739
9740
9743
9780
9800
9801
Schedule
Fmt 4703
Sfmt 4703
Pharmaron Manufacturing
Services (US) LLC has applied to be
registered as a bulk manufacturer of
basic class(es) of controlled
substance(s). Refer to SUPPLEMENTARY
INFORMATION listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before July 5, 2024. Such persons
may also file a written request for a
hearing on the application on or before
July 5, 2024.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
SUMMARY:
E:\FR\FM\06MYN1.SGM
06MYN1
Agencies
[Federal Register Volume 89, Number 88 (Monday, May 6, 2024)]
[Notices]
[Pages 37257-37260]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-09811]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1361]
Importer of Controlled Substances Application: NSI Lab Solutions,
Inc.
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: NSI Lab Solutions, Inc. has applied to be registered as an
importer of basic class(es) of controlled substance(s). Refer to
SUPPLEMENTARY INFORMATION listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may submit electronic comments on or
objections to the issuance of the proposed registration on or before
June 5, 2024. Such persons may also file a written request for a
hearing on the application on or before June 5, 2024.
ADDRESSES: The Drug Enforcement Administration requires that all
comments be submitted electronically through the Federal eRulemaking
Portal, which provides the ability to type short comments directly into
the comment field on the web page or attach a file for lengthier
comments. Please go to https://www.regulations.gov and follow the
online instructions at that site for submitting comments. Upon
submission of your comment, you will receive a Comment Tracking Number.
Please be aware that submitted comments are not instantaneously
available for public view on https://www.regulations.gov. If you have
received a Comment Tracking Number, your comment has been successfully
submitted and there is no need to resubmit the same comment. All
requests for a hearing must be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152. All requests for a hearing should also be
sent to: Drug Enforcement Administration, Attn: Administrator, 8701
Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on March 22, 2024, NSI Lab Solutions, Inc., 7212 ACC
Boulevard, Raleigh, North Carolina 27617, applied to be registered as
an importer of the following basic class(es) of controlled
substance(s):
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
3-Fluoro-N-methylcathinone (3-FMC)... 1233 I
Cathinone............................ 1235 I
Methcathinone........................ 1237 I
4-Fluoro-N-methylcathinone (4-FMC)... 1238 I
Pentedrone ([alpha]- 1246 I
methylaminovalerophenone).
Mephedrone (4-Methyl-N- 1248 I
methylcathinone).
4-Methyl-N-ethylcathinone (4-MEC).... 1249 I
Naphyrone............................ 1258 I
3-methylmethcathinone (2- 1259 I
(methylamino)-1-(3-
methylphenyl)propan-1-one).
N-Ethylamphetamine................... 1475 I
Methiopropamine (N-methyl-1-(thiophen- 1478 I
2-yl)propan-2- amine).
N,N-Dimethylamphetamine.............. 1480 I
Fenethylline......................... 1503 I
Aminorex............................. 1585 I
4-Methylaminorex (cis isomer)........ 1590 I
4,4'-Dimethylaminorex (4,4'-DMAR; 4,5- 1595 I
dihydro-4- methyl-5-(4-methylphenyl)-
2-oxazolamine; 4-methyl-5- (4-
methylphenyl)-4,5-dihydro-1,3-oxazol-
2-amine).
[[Page 37258]]
Gamma Hydroxybutyric Acid............ 2010 I
Methaqualone......................... 2565 I
Etizolam (4-(2-chlorophenyl)-2-ethyl- 2780 I
9-methyl-6H-thieno[3,2-
f][1,2,4]triazolo[4,3-
a][1,4]diazepine.
Flualprazolam (8-chloro-6-(2- 2785 I
fluorophenyl)-1-methyl-4H-
benzo[f][1,2,4]triazolo[4,3-
a][1,4]diazepine).
Clonazolam (6-(2-chlorophenyl)-1- 2786 I
methyl-8-nitro-4H-
benzo[f][1,2,4]triazolo[4,3-
a][1,4]diazepine.
Flubromazolam (8-bromo-6-(2- 2788 I
fluorophenyl)-1-methyl-4H-
benzo[f][1,2,4]triazolo[4,3-
a][1,4]diazepine.
Diclazepam (7-chloro-5-(2-chloro-5-(2- 2789 I
chlorophenyl)-1- methyl-1,3-dihydro-
2H-benzo[e][1,4]diazepin-2-one.
JWH-250 (1-Pentyl-3-(2- 6250 I
methoxyphenylacetyl) indole).
SR-18 (Also known as RCS-8) (1- 7008 I
Cyclohexylethyl-3-(2-
methoxyphenylacetyl) indole).
ADB-FUBINACA (N-(1-amino-3,3-dimethyl- 7010 I
1-oxobutan-2-yl)-1-(4-fluorobenzyl)-
1H-indazole-3-carboxamide).
5-Fluoro-UR-144 and XLR11 ([1-(5- 7011 I
Fluoro-pentyl)1H-indol-3-yl]
(2,2,3,3-
tetramethylcyclopropyl)methanone).
AB-FUBINACA (N-(1-amino-3-methyl-1- 7012 I
oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-
indazole-3-carboxamide).
(1-(4-Fluorobenzyl)-1H-indol-3- 7014 I
yl)(2,2,3,3-
tetramethylcyclopropyl)methanone.
JWH-019 (1-Hexyl-3-(1-naphthoyl) 7019 I
indole).
MDMB-FUBINACA (Methyl 2-(1-(4- 7020 I
fluorobenzyl)-1H-indazole-3-
carboxamido)-3,3-dimethylbutanoate).
FUB-AMB, MMB-FUBINACA, AMB-FUBINACA 7021 I
(2-(1-(4-fluorobenzyl)-1Hindazole-3-
carboxamido)-3-methylbutanoate).
AB-PINACA (N-(1-amino-3-methyl-...... 7023 I
1-oxobutan-2-yl)-1-pentyl-1H-indazole-
)3-carboxamide.
THJ-2201 ([1-(5-fluoropentyl)-1H- 7024 I
indazol-3-.
yl](naphthalen-1-yl)methanone).......
5F-AB-PINACA (N-(1-amino-3methyl-1- 7025 I
oxobutan-2-yl)-1-(5-fluoropentyl)-1H-
indazole-3-carboxamide).
ADB-BUTINACA (N-(1-amino-3,3-dimethyl- 7027 I
1-oxobutan2-yl)-1-butyl-1H-indazole-
3-carb.
AB-CHMINACA (N-(1-amino-3-methyl-1-.. 7031 I
oxobutan-2-yl)-1-(cyclohexylmethyl)-.
1H-indazole-3-carboxamide)...........
MAB-CHMINACA (N-(1-amino-3,3dimethyl- 7032 I
1-oxobutan-2-yl)-1-
(cyclohexylmethyl)-1H-indazole-3-
carboxamide).
5F-AMB (Methyl 2-(1-(5-fluoropentyl)- 7033 I
1H-indazole-3-carboxamido)-3-
methylbutanoate).
ADB-PINACA (N-(1-amino-3,3-dimethyl-1- 7035 I
oxobutan-2-yl)-1-pentyl-1H-indazole-
3-carboxamide).
Methyl 2-(1-(5-fluoropentyl)-1H- 7041 I
indole-3-carboxamido)- 3,3-
dimethylbutanoate.
MDMB-CHMICA, MMB-CHMINACA (Methyl 2- 7042 I
(1-(cyclohexylmethyl)-1H-indole-3-
carboxamido)-3,3-dimethylbutanoate).
4F-MDMB-BINACA (4F-MDMB-BUTINACA or 7043 I
methyl 2- (1-(4-fluorobutyl)-1H-
indazole-3-carboxamido)-3,3-
dimethylbutanoate).
MMB-CHMICA, AMB-CHMICA (methyl 2-(1- 7044 I
(cyclohexylmethyl)-1H-indole-3-
carboxamido)-3-methylbutanoate).
APINACA and AKB48 (N-(1-Adamantyl)-1- 7048 I
pentyl-1H-indazole-3-carboxamide).
JWH-081 (1-Pentyl-3-(1-(4- 7081 I
methoxynaphthoyl) indole).
MDMB-4en-PINACA (methyl 3,3-dimethyl- 7090 I
2-(1-(pent-4- en-1-yl)-1H-indazole-3-
carboxamido)butanoate).
SR-19 (Also known as RCS-4) (1-Pentyl- 7104 I
3-[(4-methoxy)-benzoyl] indole).
JWH-018 (also known as AM678) (1- 7118 I
Pentyl-3-(1-naphthoyl)indole).
JWH-122 (1-Pentyl-3-(4-methyl-1- 7122 I
naphthoyl) indole).
UR-144 (1-Pentyl-1H-indol-3- 7144 I
yl)(2,2,3,3-
tetramethylcyclopropyl)methanone).
JWH-073 (1-Butyl-3-(1- 7173 I
naphthoyl)indole).
JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3- 7200 I
(1-naphthoyl)indole).
AM2201 (1-(5-Fluoropentyl)-3-(1- 7201 I
naphthoyl) indole).
JWH-203 (1-Pentyl-3-(2- 7203 I
chlorophenylacetyl) indole).
NM2201, CBL2201 (Naphthalen-1-yl 1-(5- 7221 I
fluoropentyl)-1H-indole-3-
carboxylate).
PB-22 (Quinolin-8-yl 1-pentyl-1H- 7222 I
indole-3-carboxylate).
5F-PB-22 (Quinolin-8-yl 1-(5- 7225 I
fluoropentyl)-1H-indole-3-
carboxylate).
Alpha-ethyltryptamine................ 7249 I
Ibogaine............................. 7260 I
Lysergic acid diethylamide........... 7315 I
Marihuana extract.................... 7350 I
Marihuana............................ 7360 I
Tetrahydrocannabinols................ 7370 I
Mescaline............................ 7381 I
JWH-398 (1-Pentyl-3-(4-chloro-1- 7398 I
naphthoyl) indole).
3,4-Methylenedioxyamphetamine........ 7400 I
3,4-Methylenedioxymethamphetamine.... 7405 I
Alpha-methyltryptamine............... 7432 I
Bufotenine........................... 7433 I
Diethyltryptamine.................... 7434 I
Dimethyltryptamine................... 7435 I
Psilocybin........................... 7437 I
Psilocyn............................. 7438 I
4-chloro-alpha- 7443 I
pyrrolidinovalerophenone (4-chloro-a-
PVP).
N-Benzylpiperazine................... 7493 I
2C-I (2-(4-iodo-2,5-dimethoxyphenyl) 7518 I
ethanamine).
2C-N (2-(2,5-Dimethoxy-4-nitro- 7521 I
phenyl) ethanamine).
2C-P (2-(2,5-Dimethoxy-4-(n)- 7524 I
propylphenyl) ethanamine).
MDPV (3,4-Methylenedioxypyrovalerone) 7535 I
2-(4-chloro-2,5-dimethoxyphenyl)-N-(2- 7537 I
methoxybenzyl) ethanamine (25C-
NBOMe).
Methylone (3,4-Methylenedioxy-N- 7540 I
methylcathinone).
Butylone............................. 7541 I
Pentylone............................ 7542 I
[[Page 37259]]
N-Ethylpentylone, ephylone (1-(1,3- 7543 I
benzodioxol-5-yl)-2-(ethylamino)-
pentan-1-one).
[alpha]-PVP (alpha- 7545 I
pyrrolidinopentiophenone).
[alpha]-PBP (alpha- 7546 I
pyrrolidinobutiophenone).
Ethylone............................. 7547 ....................
PV8, alpha-Pyrrolidinoheptaphenone... 7548 I
Eutylone............................. 7549 I
[alpha]-PiHP (4-methyl-1-phenyl-2- 7551 I
(pyrrolidin-1-yl)pentan-1- one).
AM-694 (1-(5-Fluoropentyl)-3-(2- 7694 I
iodobenzoyl) indole).
Acetyldihydrocodeine................. 9051 I
Codeine-N-oxide...................... 9053 I
Desomorphine......................... 9055 I
Brorphine (1-(1-(1-(4- 9098 I
bromophenyl)ethyl)piperidin-4-yl)-
1,3-dihydro-2H-benzo[d]imidazol-2-
one).
Heroin............................... 9200 I
Morphine-N-oxide..................... 9307 I
Myrophine............................ 9308 I
Nicomorphine......................... 9312 I
Normorphine.......................... 9313 I
Pholcodine........................... 9314 I
Thebacon............................. 9315 I
U-47700 (3,4-dichloro-N-[2- 9547 I
(dimethylamino)cyclohexyl]-N-
methylbenzamide).
AH-7921 (3,4-dichloro-N-[(1- 9551 I
dimethylamino)cyclohexylmethyl]benza
mide)).
MT-45 (1-cyclohexyl-4-(1,2- 9560 I
diphenylethyl)piperazine)).
Isotonitazene (N,N-diethyl-2-(2-(4 9614 I
isopropoxybenzyl)-5- nitro-1H-
benzimidazol-1-yl)ethan-1-amine).
Dimethylthiambutene.................. 9619 I
Dipipanone........................... 9622 I
Etonitazene.......................... 9624 I
Ketobemidone......................... 9628 I
Tilidine............................. 9750 I
Butonitazene (2-(2-(4-butoxybenzyl)-5- 9751 I
nitro-1Hbenzimidazol-1-yl)-N,N-
diethylethan-1.
Flunitazene (N,N-diethyl-2-(2-(4- 9756 I
fluorobenzyl)-5-nitro1H-benzimidazol-
1-yl)ethan-1-amine).
Metonitazene (N,N-diethyl-2-(2-(4- 9757 I
methoxybenzyl)-5- nitro-1H-
benzimidazol-1-yl)ethan-1-amine).
N-pyrrolidino etonitazene; 9758 I
etonitazepyne (2-(4-ethoxybenzyl)-5-
nitro-1-(2- (pyrrolidin-1-yl)ethyl)-
1H-benzimidazole).
Metodesnitazene (N,N-diethyl-2-(2-(4- 9759 I
methoxybenzyl)- 1H-benzimidazol-1-
yl)ethan-1-amine).
Metodesnitazene (N,N-diethyl-2-(2-(4- 9764 I
methoxybenzyl)- 1H-benzimidazol-1-
yl)ethan-1-amine).
Etodesnitazene; etazene (2-(2-(4- 9765 I
ethoxybenzyl)-1Hbenzimidazol-1-yl)-
N,N-diethyleth.
Acryl fentanyl (N-(1- 9811 I
phenethylpiperidin-4-yl)-N-
phenylacrylamide).
Para-Fluorofentanyl.................. 9812 I
3-Methylfentanyl..................... 9813 I
Alpha-Methylfentanyl................. 9814 I
Acetyl Fentanyl (N-(1- 9821 I
phenethylpiperidin-4-yl)-N-
phenylacetamide).
Butyryl Fentanyl..................... 9822 I
Para-fluorobutyryl fentanyl.......... 9823 I
4-Fluoroisobutyryl fentanyl (N-(4- 9824 I
fluorophenyl)-N-(1-
phenethylpiperidin-4-
yl)isobutyramide).
2-methoxy-N-(1-phenethylpiperidin-4- 9825 I
yl)-N-phenylacetamide.
Para-chloroisobutyryl fentanyl....... 9826 I
Isobutyryl fentanyl.................. 9827 I
Furanyl fentanyl (N-(1- 9834 I
phenethylpiperidin-4-yl)-N-
phenylfuran-2-carboxamide).
Thiofentanyl......................... 9835 I
Beta-hydroxythiofentanyl............. 9836 I
Ocfentanil........................... 9838 I
Valeryl fentanyl..................... 9840 I
Phenyl fentanyl (N-(1- 9841 I
phenethylpiperidin-4-yl)-
Nphenylbenzamide; also known as
benzoyl fentanyl).
beta'-Phenyl fentanyl (N-(1- 9842 I
phenethylpiperidin-4-yl)-N,3-
diphenylpropanamide; also known as
[beta]'-phenyl fentanyl; 3-
phenylpropanoyl fentanyl).
N-(1-phenethylpiperidin-4-yl)-N- 9843 I
phenyltetrahydrofuran-2-carboxamide).
Crotonyl fentanyl ((E)-N-(1- 9844 I
phenethylpiperidin-4-yl)-Nphenylbut-
2-enam.
Cyclopropyl Fentanyl................. 9845 I
Cyclopentyl fentanyl................. 9847 I
Fentanyl related-compounds as defined 9850 I
in 21 CFR 1308.11(h).
2'-Fluoro ortho-fluorofentanyl (N-(1- 9855 I
(2- fluorophenethyl)piperidin-4-yl)-
N-(2- fluorophenyl)propionamide;
also known as 2'-fluoro 2-
fluorofentanyl).
Amphetamine.......................... 1100 II
Methamphetamine...................... 1105 II
ANPP (4-Anilino-N-phenethyl-4- 8333 II
piperidine).
Norfentanyl (N-phenyl-N-(piperidin-4- 8366 II
yl)propionamide).
1-Piperidinocyclohexanecarbonitrile.. 8603 II
Cocaine.............................. 9041 II
Codeine.............................. 9050 II
Dihydrocodeine....................... 9120 II
Oxycodone............................ 9143 II
Hydromorphone........................ 9150 II
Diphenoxylate........................ 9170 II
Ecgonine............................. 9180 II
Ethylmorphine........................ 9190 II
[[Page 37260]]
Hydrocodone.......................... 9193 II
Levorphanol.......................... 9220 II
Isomethadone......................... 9226 II
Meperidine........................... 9230 II
Meperidine-intermediate-A............ 9232 II
Meperidine intermediate-B............ 9233 II
Meperidine intermediate-C............ 9234 II
Methadone............................ 9250 II
Methadone intermediate............... 9254 II
Dextropropoxyphene, bulk (non-dosage 9273 II
forms).
Morphine............................. 9300 II
Oripavine............................ 9330 II
Thebaine............................. 9333 II
Opium, raw........................... 9600 II
Opium extracts....................... 9610 II
Opium fluid extract.................. 9620 II
Opium tincture....................... 9630 II
Opium, powdered...................... 9639 II
Opium, granulated.................... 9640 II
Oxymorphone.......................... 9652 II
Noroxymorphone....................... 9668 II
Alfentanil........................... 9737 II
Remifentanil......................... 9739 II
Sufentanil........................... 9740 II
Carfentanil.......................... 9743 II
Tapentadol........................... 9780 II
Bezitramide.......................... 9800 II
Fentanyl............................. 9801 II
------------------------------------------------------------------------
The company plans to import the listed controlled substances for
sale to research facilities for drug testing and analysis. In reference
to drug codes 7360 (Marihuana) and 7370 (Tetrahydrocannabinols) the
company plans to import a synthetic cannabidiol and a synthetic
tetrahydrocannabinol. No other activities for these drug codes are
authorized for this registration.
Approval of permit applications will occur only when the
registrant's business activity is consistent with what is authorized
under 21 U.S.C. 952(a)(2). Authorization will not extend to the import
of Food and Drug Administration-approved or non-approved finished
dosage forms for commercial sale.
Marsha Ikner,
Acting Deputy Assistant Administrator.
[FR Doc. 2024-09811 Filed 5-3-24; 8:45 am]
BILLING CODE 4410-09-P